Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

51281 - 51290 of 57354 results found

Impact of COVID-19 pneumonia on pulmonary vascular volume

Date
Monday, April 10, 2023 - 4:00 AM
Description
CONCLUSION: Vascular volume in COVID-19 affected lung parenchyma is augmented relative to normal lung parenchyma, indicating venous congestion and supporting the hypothesis of pre-existing intra-pulmonary arteriovenous shunts.

AI and data science for smart emergency, crisis and disaster resilience

Date
Monday, April 10, 2023 - 4:00 AM
Description
The uncertain world has seen increasing emergencies, crises and disasters (ECDs), such as the COVID-19 pandemic, hurricane Ian, global financial inflation and recession, misinformation disaster, and cyberattacks. AI for smart disaster resilience

Harnessing heterogeneity in space with statistically guided meta-learning

Date
Monday, April 10, 2023 - 4:00 AM
Description
Spatial data are ubiquitous, massively collected, and widely used to support critical decision-making in many societal domains, including public health (e.g., COVID-19 pandemic control), agricultural crop monitoring, transportation, etc. While recent

Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SAR...

Date
Monday, April 10, 2023 - 4:00 AM
Description
The human infectious disease COVID-19 caused by the SARS-CoV-2 virus has become a major threat to global public health. Developing a vaccine is the preferred prophylactic response to epidemics and pandemics. However, for individuals who have

Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SAR...

Date
Monday, April 10, 2023 - 4:00 AM
Description
The human infectious disease COVID-19 caused by the SARS-CoV-2 virus has become a major threat to global public health. Developing a vaccine is the preferred prophylactic response to epidemics and pandemics. However, for individuals who have